Deal diagnosis
Separate the visible stall from the underlying cause across urgency, consensus, value, process, and competition.
AI deal intelligence for enterprise sales
WinSignal diagnoses why complex B2B opportunities are slipping, maps the people and threats shaping the decision, and produces a specific strategy your team can execute.
Built for sales leaders, account executives, and deal teams working complex, high-value opportunities.
What to expect
No invented certainty
Assumptions, evidence gaps, and confidence levels stay visible.
Actionable output
Every assessment ends with prioritized moves, not generic advice.
Respectful handling
Public autopsies are anonymized; sensitive deal work stays scoped.
The Deal Autopsy
WinSignal turns scattered notes and intuition into a structured view of the decision—and a practical plan for changing it.
Separate the visible stall from the underlying cause across urgency, consensus, value, process, and competition.
Identify champions, blockers, economic buyers, missing voices, and the relationships shaping the decision.
Read the real contest—including incumbency, internal alternatives, procurement pressure, and no decision.
Turn the evidence into prioritized actions, stakeholder moves, proof points, and a defensible next step.
Ways to engage
Start with a focused assessment or bring WinSignal into the room for the opportunities that cannot be left to instinct.
Assessment
Fast diagnosis for one active opportunity
$295
Strategy report
Deeper analysis and a tailored win plan
$1,500
Advisory
Facilitated review for strategic pursuits
Custom
Prices shown in USD. Scope is confirmed before work begins; no hidden setup fees.
Straight answers
Your next move
Bring WinSignal one important opportunity. Leave with a clearer diagnosis and a strategy your team can act on.